title: [Autosomal dominant polycystic kidney disease: new insights and possible drugs].
authors.affiliation: Universitair Medisch Centrum Groningen, Groningen.
authors.forename: Esther
authors.initials: E
authors.lastname: Meijer
authors.forename: Paul E
authors.initials: PE
authors.lastname: de Jong
authors.forename: Eric J
authors.initials: EJ
authors.lastname: van der Jagt
authors.forename: D orienJ
authors.initials: Do
authors.lastname: Peters
authors.forename: Martijn H
authors.initials: MH
authors.lastname: Breuning
authors.forename: Ron T
authors.initials: RT
authors.lastname: Gansevoort
mesh_terms: D065092:Antidiuretic Hormone Receptor Antagonists; D003937:Diagnosis, Differential; D006801:Humans; D016891:Polycystic Kidney, Autosomal Dominant / Q000453:epidemiology* / Q000503:physiopathology / Q000628:therapy; D015995:Prevalence; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011494:Protein Kinases; D058570:TOR Serine-Threonine Kinases
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases